4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001087294-26-000033
Options or other derivatives
- VP Chief Financial Officer acquired 3,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hamm John M. VP Chief Financial Officer | 2026-03-18 | Grant or award · Options (right to buy) | +3,000 | $2.80 | $8,400 | 18,250 | D |
Loading xslF345X06/wk-form4_1774041628.xml…